B3 agonists or anticholinergics in the treatment of the lower urinary tract dysfunction in patients with multiple sclerosis? —A randomized study

ConclusionsMS patients receiving either mirabegron or anticholinergic therapy for LUTD showed improvement. Nevertheless, no statistical difference was noted between the two cohorts at 3  months in terms of drug efficacy in all the statistically significant parameters.
Source: World Journal of Urology - Category: Urology & Nephrology Source Type: research